A comprehensive view of prescription drugs. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Novartis gains FDA approval for Fabhalta as first oral monotherapy for adults with paroxysmal nocturnal hemoglobinuria, a rare blood disorder; Fabhalta offers an alternative to existing C5 inhibitor treatments that often leave symptoms uncontrolled

Daiichi Sankyo's subsidiary Plexxikon settles patent infringement lawsuit with Novartis over the sale of the Novartis BRAF inhibitor Tafinlar in the US; Plexxikin receives US$182.0M settlement

CVS Health plans to overhaul its current pharmacy reimbursement model for prescription medications, adopting a more transparent pricing approach; the new model, CostVantage, will launch in 2025, alongside a new PBM operation model, TrueCost

ETH Zurich and Roche Pharma Research use AI to predict how pharmaceutically active molecules can be chemically modified to accelerate new pharma ingredient identification and optimize existing ingredients

Eli Lilly extends expiration of tender offer to acquire Point Biopharma until Dec. 15, 2023 for $12.50 per share

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count